Active and passive immunotherapy: vaccines and antibodies.

about

Development and characterization of an antibody-labeled super-paramagnetic iron oxide contrast agent targeting prostate cancer cells for magnetic resonance imaging.In Vivo 3T Magnetic Resonance Imaging Using a Biologically Specific Contrast Agent for Prostate Cancer: A Nude Mouse Model

P2860

Q31161048-F4617B62-3F44-4B82-ADB8-28AF155F1DC0 Q59146880-28552EA6-3F50-4870-9478-69264C981D13

P2860

Active and passive immunotherapy: vaccines and antibodies.

Item

http://www.wikidata.org/entity/Q36794818

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Active and passive immunotherapy: vaccines and antibodies.

@ast

Active and passive immunotherapy: vaccines and antibodies.

@en

type

Item

label

Active and passive immunotherapy: vaccines and antibodies.

@ast

Active and passive immunotherapy: vaccines and antibodies.

@en

prefLabel

Active and passive immunotherapy: vaccines and antibodies.

@ast

Active and passive immunotherapy: vaccines and antibodies.

@en

P1476

Active and passive immunotherapy: vaccines and antibodies.

@en

P2093

Chaitanya Divgi

http://www.w3.org/2001/XMLSchema#string

Egbert Oosterwijk

http://www.w3.org/2001/XMLSchema#string

Neil H Bander

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250

A phase I trial of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma.

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.

A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients.

Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma.

Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma.

Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: a phase 1 study.

P304

1301-1304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1464-410X.2007.06835.X

http://www.w3.org/2001/XMLSchema#string

P433

5 Pt B

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17441928

http://www.w3.org/2001/XMLSchema#string

Active and passive immunotherapy: vaccines and antibodies.

about

P2860

P2860

Active and passive immunotherapy: vaccines and antibodies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698